(E)-4-(2-(2,5-Dioxopyrrolidin-1-yl)ethoxy)-4-oxobut-2-enoic acid
- CAS
- 2101811-41-8
- Formula
- C10H11NO6
- MW
- 241.2 g/mol
VQ-025349
Impurity reference standards
Diroximel Fumarate impurities & reference standards
Characterised Diroximel Fumarate impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
11reference materials
COAHPLC · NMR · MS on request
Parent API: Diroximel Fumarate
1577222-14-0 · C11H13NO6
FAQs — Diroximel Fumarate impurities
Which Diroximel Fumarate impurities do you supply?
We list 11 Diroximel Fumarate-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Diroximel Fumarate impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Diroximel Fumarate impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Diroximel Fumarate impurity standards
We reply within one business day with price, pack options, lead time and documentation.